During the follow-up period, ten patients developed arterial hypertension (all treated with angiotensin-converting enzyme inhibitors), one developed insulin-dependent diabetes and four developed dyslipidaemia (all treated with statins). The gene discussed is ACE; the disease is Hypertension.